Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 452
Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
Times cited: 113